Board of Directors Colin Goddard, Ph.D. Chairman of the Board and Chief Executive Officer Edwin A. Gee, Ph.D. Chairman, Emeritus Former Chairman & CEO International Paper, Inc. G. Morgan Browne Chief Financial Officer Cold Spring Harbor Laboratory John H. French II Vice Chairman, Southern Pacific Petroleum (US) and Vice Chairman, Company of the Far Countries Daryl K. Granner, M.D. Director, Vanderbilt Diabetes Center Professor, Molecular Physiology and Biophysics, Vanderbilt University Walter M. Lovenberg, Ph.D. Former Executive Vice President Marion Merrell Dow Inc. Viren Mehta Mehta Partners LLC Sir Mark Richmond Senior Fellow University College, London Formerly Head of Research and Special Assignments, Glaxo Research & Development John P. White, Esq. Partner Cooper & Dunham LLP Senior Management Colin Goddard, Ph.D. Chairman of the Board and Chief Executive Officer Nicole Onetto, M.D. Executive Vice President, Oncology Division Head Arthur M. Bruskin, Ph.D. Executive Vice President, Global Research Robert L. Van Nostrand Vice President and Chief Financial Officer Barbara A. Wood, Esq. General Counsel Linda E. Amper, Ph.D. Vice President, Human Resources and Administration Raymond Bendele, D.V.M., Ph.D. Vice President, Pharmaceutical Development Arlindo L. Castelhano, Ph.D. Vice President, U.S. Chemistry Eric W. Collington, Ph.D. Vice President, Corporate Strategic Affairs Geoffrey Cooper, Ph.D. Vice President, Business Development Neil Gibson, Ph.D. Vice President, U.S. Research John Murray, Ph.D. Vice President, U.K. Chemistry Pedro Santabárbara, M.D., Ph.D. Vice President, Clinical Research Oncology Robert L. Simon Vice President, Global Regulatory Affairs John A. Slack, Ph.D. Vice President, Development Back to Top Corporate Headquarters OSI Pharmaceuticals, Inc. 58 South Service Road Suite 110 Melville, NY 11747 Other Company Locations OSI Pharmaceuticals (UK) Limited Watlington Road Oxford, OX4 6LT United Kingdom OSI Pharmaceuticals (Boulder) 2860 Wilderness Place Boulder, CO 80301 OSI Pharmaceuticals (US Research) 106 Charles Lindbergh Blvd. Uniondale, NY 11553 Transfer Agent & Registrar Bank of New York 101 Barclay Street New York, NY 10286 (800) 524-4458 http://stock.bankofny.com Corporate Counsel Saul Ewing LLP Centre Square West 1500 Market Street Philadelphia, PA 19102 General Counsel Mintz, Levin 666 Third Avenue New York, NY 10017 Patent Counsel Cooper & Dunham LLP 1185 Avenue of The Americas New York, NY 10036 Auditors KPMG LLP 1305 Walt Whitman Road Melville, NY 11747 Annual Meeting The annual meeting of shareholders will be held on March 13, 2002 at 10:00AM at OSI Pharmaceuticals Corporate Headquarters 58 South Service Road Melville, NY 11747 Annual Report on Form 10-K The Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission and other information may be obtained without charge by writing, phoning or visiting our website: OSI Pharmaceuticals, Inc. 58 South Service Road Suite 110 Melville, NY 11747 (631) 962-2000 www.osip.com Stock Listing Nasdaq: OSIP Back to Top